TITLE

MERCK SERONO AMONG WINNERS IN GERMAN BIOPHARM COMPETITION

PUB. DATE
November 2008
SOURCE
Worldwide Biotech;Nov2008, Vol. 20 Issue 11, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article announces that Merck Serono is among the winners of the BioPharma strategy competition organized by Germany's Federal Ministry of Education and Research (BMBF) as part of its Pharmaceuticals Initiative.
ACCESSION #
34959888

 

Related Articles

  • Pharma: Other News To Note.  // BioWorld Today;11/18/2013, Vol. 24 Issue 222, p10 

    This section offers news briefs on the pharmaceutical industry including the plan of Merck KGaA's Merck Serono to invest €80 million for the construction of a facility in Nantong Economical Technological Development Area near Shanghai, China and the approval of Valeant Pharmaceuticals...

  • Unapproved herpes drug confiscated, trail followed. Blumenthal, D.; Farley, D. // FDA Consumer;Oct90, Vol. 24 Issue 8, p34 

    Gives details in a Food and Drug Administration investigation of BioPharma, Inc. The firm promoted an inactive ingredient in ImmuVir ointment as a treatment for herpes simplex which led to seizure by the FDA.

  • INDUSTRY INSIGHTS.  // Pharmaceutical Executive;May2009, Vol. 29 Issue 5, p13 

    The article offers news briefs related to the pharmaceutical industry in the U.S. Companies are fighting for strong relationships with key opinion leaders (KOLs). Pharmaceutical executives presented a four-part series about the things to know and do to properly negotiate post-employment...

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;4/14/2012, Issue 1397, p2 

    This section offers news briefs on the pharmaceutical industry. Merck Serono has warned healthcare professionals in Ireland to take risk minimization measures to avoid accidental overdose when switching patients between Siazen formulations. Companies were requested by Health Canada to add risk...

  • ASCO 2011: Erbitux Increased Overall Survival by 5.1 Months in Patients With mCRC That Has Spread Beyond the Liver.  // Biomedical Market Newsletter;6/9/2011, p683 

    The article reports on the presentation of Merck Serono of Merck KGaA on its retrospective analysis of the Crystal trial on efficacy of Erbitux® (cetuximab) in improving the outcomes in metastatic colorectal cancer (mCRC) patients. It states that the analysis has examined the benefits of...

  • Old McDonald Had a Leech Farm.  // Odyssey;Mar2010, Vol. 19 Issue 3, p37 

    The article presents information on the British company Biopharm Inc., which was the only supplier of medical leeches in the world until very recently.

  • New 'Genesis' for Viragen's Anti-CD55 Cancer Program.  // Bioworld Week;12/20/2010, Vol. 18 Issue 51, p5 

    The article reports that Genesis Biopharma Inc. is planning to do further studies on Viragen Inc's monoclonal antibody targeting CD55, after Genesis acquired license to CD55-related assets.

  • Financings Roundup.  // BioWorld Today;5/9/2012, Vol. 23 Issue 90, p8 

    The article reports on the 16.5 million dollars worth of funds raised by Sutro Biopharma Inc. in the secone tranche of its Series C financing.

  • TenX Biopharma Licenses Zanolimumab From Genmab.  // BioPharm International;Mar2010, Vol. 23 Issue 3, p16 

    The article reports on TenX Biopharma Inc. in Philadelphia, Pennsylvania which has made an agreement to purchase an international exclusive rights to develop and commercialize Genmab's zanolimumab, a medicine to treat head and neck cancer.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics